Immediate Impact
54 standout
Citing Papers
Colorectal cancer
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
Works of Peter Klare being referenced
Abstract S2-04: Early survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative and HER2-positive early breast cancer (GeparSixto)
2016
Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Klare | 729 | 361 | 335 | 89 | 1.3k | |
| Jérôme Alexandre | 791 | 506 | 286 | 92 | 1.6k | |
| Mesut Şeker | 598 | 473 | 399 | 97 | 1.3k | |
| Bala Başak Öven Ustaalıoğlu | 509 | 424 | 355 | 84 | 1.1k | |
| Ying Chen | 803 | 354 | 276 | 82 | 1.4k | |
| Pınar Saip | 590 | 505 | 316 | 113 | 1.5k | |
| Nurullah Zengin | 767 | 468 | 286 | 158 | 1.4k | |
| Yeşim Eralp | 532 | 269 | 186 | 91 | 1.2k | |
| Suresh C. Sharma | 166 | 192 | 409 | 69 | 1.1k | |
| Israel Zighelboim | 315 | 230 | 438 | 70 | 1.5k | |
| Ricardo Cubedo | 551 | 619 | 216 | 48 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...